Targeted Strategies for Today's Evolving Markets

MissionIR Blog

BSD Medical Corp. (BSDM) Reports on MicroThermX Clinical Evaluations

BSD Medical Corp. develops, manufacturers, markets, and services systems to treat cancer and benign diseases using heat therapy delivered using focused radio frequency (RF) and microwave energy.

One of the company’s premier line of products is the MicroThermX Microwave Ablation System. It is a compact, mobile, state-of-the-art, proprietary system that includes a microwave generator, single-patent-use disposable antennas and a thermistor-based temperature monitoring system.

The company, on June 16th, reported positive results from the efforts of its sales and distribution network for the MicroThermX Microwave Ablation line of products. At the hospital level, more MicroThermX trained sales representatives are representing the advantages of the MicroThermX to those physicians interested in using a microwave technology platform for tumor ablations.

This increased sales activity has resulted in a full schedule of clinical evaluations in the coming weeks. These evaluations represent an important milestone in the MicroThermX sales cycle, with hospital capital budgeting, committee review and other approvals required to complete the sales cycle.

The company is excited by the initial sales from the rollout of its sales and marketing strategy. It also points to the medical facilities where BSD initially placed the systems and the reorders of the disposable microwave antennas as a positive indicator of its potential ongoing revenue stream.

For additional information on BSD Medical, please visit its website at

Let us hear your thoughts below:

This entry was posted in Small Cap News. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *